Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.100 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.44 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.20.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.105EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used